NO20063757L - Substituerte N-cykloheksylimidazolrnoner med en MCH-modulatorisk virkning - Google Patents
Substituerte N-cykloheksylimidazolrnoner med en MCH-modulatorisk virkningInfo
- Publication number
- NO20063757L NO20063757L NO20063757A NO20063757A NO20063757L NO 20063757 L NO20063757 L NO 20063757L NO 20063757 A NO20063757 A NO 20063757A NO 20063757 A NO20063757 A NO 20063757A NO 20063757 L NO20063757 L NO 20063757L
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- cyclohexylimidazolones
- compounds
- modulatory effect
- preparation
- Prior art date
Links
- ORHUTCSWNIEAEI-UHFFFAOYSA-N 3-cyclohexyl-1h-imidazol-2-one Chemical class O=C1NC=CN1C1CCCCC1 ORHUTCSWNIEAEI-UHFFFAOYSA-N 0.000 title 1
- 230000000897 modulatory effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004003811A DE102004003811A1 (de) | 2004-01-25 | 2004-01-25 | Substituierte N-Cyclohexylimidazolinone, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP2005/000700 WO2005070898A1 (fr) | 2004-01-25 | 2005-01-25 | N-cyclohexylimidazolinone substituee a effet modulateur mch |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063757L true NO20063757L (no) | 2006-10-11 |
Family
ID=34745115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063757A NO20063757L (no) | 2004-01-25 | 2006-08-22 | Substituerte N-cykloheksylimidazolrnoner med en MCH-modulatorisk virkning |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1711473B1 (fr) |
| JP (1) | JP2007518771A (fr) |
| KR (1) | KR20060128955A (fr) |
| CN (1) | CN1934090B (fr) |
| AR (1) | AR047453A1 (fr) |
| AT (1) | ATE383342T1 (fr) |
| AU (1) | AU2005206308A1 (fr) |
| BR (1) | BRPI0507104A (fr) |
| CA (1) | CA2554233A1 (fr) |
| CY (1) | CY1107429T1 (fr) |
| DE (2) | DE102004003811A1 (fr) |
| DK (1) | DK1711473T3 (fr) |
| ES (1) | ES2297667T3 (fr) |
| HR (1) | HRP20080077T3 (fr) |
| IL (1) | IL176917A0 (fr) |
| MA (1) | MA28345A1 (fr) |
| MY (1) | MY139107A (fr) |
| NO (1) | NO20063757L (fr) |
| PE (1) | PE20051091A1 (fr) |
| PL (1) | PL1711473T3 (fr) |
| PT (1) | PT1711473E (fr) |
| RS (1) | RS50543B (fr) |
| RU (1) | RU2006130626A (fr) |
| TW (1) | TW200604182A (fr) |
| UY (1) | UY28726A1 (fr) |
| WO (1) | WO2005070898A1 (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2626220A1 (fr) | 2005-12-21 | 2007-06-28 | Janssen Pharmaceutica N.V. | Nouveaux derives de pyrazinone substituee a utiliser lors de maladies mediees par mch-1 |
| EP2061767B1 (fr) | 2006-08-08 | 2014-12-17 | Sanofi | Imidazolidin-2,4-diones arylaminoaryl-alkyl-substituées, procédé de fabrication, médicaments les contenant et leur utilisation |
| EP2102208B1 (fr) | 2006-12-05 | 2014-04-23 | Janssen Pharmaceutica NV | Nouveaux dérivés de diaza-spiro-pyridinone substitués pour une utilisation dans des maladies à médiation par mch-1 |
| KR100893394B1 (ko) * | 2007-05-11 | 2009-04-17 | 한국화학연구원 | 아릴 피페리딘기-함유 이미다졸 유도체, 이의 제조방법 및이를 유효성분으로 포함하는 약학적 조성물 |
| UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
| DE102008060967A1 (de) * | 2008-12-06 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Phenylsulfonyltriazolone und ihre Verwendung |
| WO2010068601A1 (fr) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant |
| KR20120060207A (ko) | 2009-08-26 | 2012-06-11 | 사노피 | 신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도 |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2012120056A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés oxathiazine tétra-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
| EP2766349B1 (fr) | 2011-03-08 | 2016-06-01 | Sanofi | Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation |
| WO2012120058A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés d'oxathiazine substitués par des groupes benzyle ou hétérométhylène, leur procédé de production, leur utilisation comme médicament ainsi que produits pharmaceutiques les contenant et leur utilisation |
| EP2683699B1 (fr) | 2011-03-08 | 2015-06-24 | Sanofi | Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
| US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| WO2012120051A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés benzyl-oxathiazine substitués avec adamantane ou noradamantane, médicaments contenant ces composés et leur utilisation |
| EP2683702B1 (fr) | 2011-03-08 | 2014-12-24 | Sanofi | Nouveaux dérivés de phényle-oxathiazine substitués, leur procédé de fabrication, médicament contenant ces liaisons et son utilisation |
| EP2683704B1 (fr) | 2011-03-08 | 2014-12-17 | Sanofi | Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation |
| PL223830B1 (pl) | 2012-04-03 | 2016-11-30 | Univ Jagiellonski | Pochodne aromatycznych imidazolidynonów i ich zastosowanie |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL162311A0 (en) * | 2001-12-04 | 2005-11-20 | Schering Corp | N-aryl-n'-arylcycloalkyl-urea derivatives aas mch antagonists for the treatment of obesity |
| DE10233817A1 (de) * | 2002-07-25 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
2004
- 2004-01-25 DE DE102004003811A patent/DE102004003811A1/de not_active Withdrawn
-
2005
- 2005-01-24 AR ARP050100240A patent/AR047453A1/es not_active Application Discontinuation
- 2005-01-25 RS RSP-2008/0082A patent/RS50543B/sr unknown
- 2005-01-25 RU RU2006130626/04A patent/RU2006130626A/ru not_active Application Discontinuation
- 2005-01-25 DE DE502005002497T patent/DE502005002497D1/de not_active Expired - Lifetime
- 2005-01-25 HR HR20080077T patent/HRP20080077T3/xx unknown
- 2005-01-25 BR BRPI0507104-6A patent/BRPI0507104A/pt not_active IP Right Cessation
- 2005-01-25 JP JP2006550073A patent/JP2007518771A/ja not_active Abandoned
- 2005-01-25 WO PCT/EP2005/000700 patent/WO2005070898A1/fr not_active Ceased
- 2005-01-25 ES ES05707002T patent/ES2297667T3/es not_active Expired - Lifetime
- 2005-01-25 MY MYPI20050274A patent/MY139107A/en unknown
- 2005-01-25 PT PT05707002T patent/PT1711473E/pt unknown
- 2005-01-25 EP EP05707002A patent/EP1711473B1/fr not_active Expired - Lifetime
- 2005-01-25 PL PL05707002T patent/PL1711473T3/pl unknown
- 2005-01-25 AT AT05707002T patent/ATE383342T1/de not_active IP Right Cessation
- 2005-01-25 AU AU2005206308A patent/AU2005206308A1/en not_active Abandoned
- 2005-01-25 TW TW094102156A patent/TW200604182A/zh unknown
- 2005-01-25 DK DK05707002T patent/DK1711473T3/da active
- 2005-01-25 UY UY28726A patent/UY28726A1/es unknown
- 2005-01-25 KR KR1020067015035A patent/KR20060128955A/ko not_active Ceased
- 2005-01-25 CN CN2005800091349A patent/CN1934090B/zh not_active Expired - Fee Related
- 2005-01-25 PE PE2005000095A patent/PE20051091A1/es not_active Application Discontinuation
- 2005-01-25 CA CA002554233A patent/CA2554233A1/fr not_active Abandoned
-
2006
- 2006-07-17 IL IL176917A patent/IL176917A0/en not_active IP Right Cessation
- 2006-08-03 MA MA29233A patent/MA28345A1/fr unknown
- 2006-08-22 NO NO20063757A patent/NO20063757L/no not_active Application Discontinuation
-
2008
- 2008-03-21 CY CY20081100322T patent/CY1107429T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL1711473T3 (pl) | 2008-05-30 |
| WO2005070898A1 (fr) | 2005-08-04 |
| DK1711473T3 (da) | 2008-05-26 |
| UY28726A1 (es) | 2005-08-31 |
| AR047453A1 (es) | 2006-01-18 |
| RU2006130626A (ru) | 2008-02-27 |
| ES2297667T3 (es) | 2008-05-01 |
| ATE383342T1 (de) | 2008-01-15 |
| AU2005206308A1 (en) | 2005-08-04 |
| TW200604182A (en) | 2006-02-01 |
| CN1934090A (zh) | 2007-03-21 |
| IL176917A0 (en) | 2006-12-10 |
| HRP20080077T3 (en) | 2008-03-31 |
| EP1711473B1 (fr) | 2008-01-09 |
| RS50543B (sr) | 2010-05-07 |
| JP2007518771A (ja) | 2007-07-12 |
| CY1107429T1 (el) | 2012-12-19 |
| CN1934090B (zh) | 2010-04-07 |
| DE502005002497D1 (de) | 2008-02-21 |
| PE20051091A1 (es) | 2006-01-23 |
| EP1711473A1 (fr) | 2006-10-18 |
| KR20060128955A (ko) | 2006-12-14 |
| PT1711473E (pt) | 2008-03-07 |
| MY139107A (en) | 2009-08-28 |
| MA28345A1 (fr) | 2006-12-01 |
| BRPI0507104A (pt) | 2007-06-19 |
| CA2554233A1 (fr) | 2005-08-04 |
| DE102004003811A1 (de) | 2005-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063757L (no) | Substituerte N-cykloheksylimidazolrnoner med en MCH-modulatorisk virkning | |
| NO20070176L (no) | Nye fluorglykosidderivater av pyrazoler, medikamenter inneholdende disse forbindelsene og anvendelse derav | |
| NO20091893L (no) | Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav. | |
| NO20050648L (no) | Heterocyklisk substituerte benzoylureaer, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter | |
| NO20064201L (no) | Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling | |
| NO20084307L (no) | Heterocykliske GPCR agonister | |
| NO20083863L (no) | Pyrazoler som 11-beta-hsd-1 | |
| NO20092651L (no) | Dihydropyridinderivater som er anvendelige som proteinkinaseinhibitorer | |
| NO20080010L (no) | GPCR-agonister | |
| NO20063925L (no) | Indazolderivater som inhibitorer av hormonsensitiv lipase | |
| NO20071776L (no) | Kinoksaliner som B RAF inhibitorer. | |
| MA32272B1 (fr) | Inhibiteurs de raf de pyrazole [3,4-b]pyridine | |
| NO20091244L (no) | Adenosinderivater som A2A reseptoragonister | |
| NO20084049L (no) | Forbindelser med forsterket ampa receptor og anvendelse derav i medisin | |
| NO20075669L (no) | Middel for a behandle ufrivillig bevegelse | |
| CR9078A (es) | Derivado de bencimidazol ariloxi-sustituidos | |
| NO20084202L (no) | 4-anilinoquinolin-3-carboksamider som CSF-1R kinase inhibitorer | |
| NO20085068L (no) | Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
| NO20060908L (no) | Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse | |
| AU2009258496A8 (en) | Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity | |
| NO20082445L (no) | Neuropeptid-2 reseptor-agonister | |
| NO20080408L (no) | Azaindazolforbindelser og anvendelse derav | |
| NO20084129L (no) | Pyridin(3,4-B)Pyrazinoner | |
| BRPI0810956A8 (pt) | "composição, método para controlar de modo preventivo ou curativo e uso da composição" | |
| WO2011028947A3 (fr) | Composés hétérocycliques pour l'inhibition de la pask |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |